Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Blue Ridge Bankshares, Inc. - BRBS


NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Blue Ridge Bankshares, Inc. ("Blue Ridge" or the "Company") (NYSE: BRBS).  Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.

The investigation concerns whether Blue Ridge and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On October 31, 2023, Blue Ridge disclosed in a filing with the U.S. Securities and Exchange Commission that its management "and the Audit Committee of its Board of Directors, after consultation with the Company's independent registered public accounting firm and its primary regulator, determined that certain specialty finance loans that, as previously disclosed, were placed on nonaccrual, reserved for, or charged off in the interim periods ended March 31, 2023 and June 30, 2023 should have been reported as nonaccrual, reserved for, or charged off in earlier periods." Accordingly, Blue Ridge advised that its "audited financial statements included in the Company's annual report on Form 10-K for the year ended December 31, 2022, and unaudited interim financial statements included in quarterly reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023 should no longer be relied upon and will be restated." Blue Ridge further advised that "[t]he effect of the adjustments will result in", among other revisions, "lower net income and earnings per share in the year ended December 31, 2022," and "that a material weakness existed in the timely risk grading, nonaccrual status, and, thus, in the determination of the adequacy of the allowance for credit losses for the specialty finance portfolio of loans[.]"  

On this news, Blue Ridge's stock price fell $1.06 per share, or 33.65%, to close at $2.09 per share on November 1, 2023.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
[email protected]
888-476-6529 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 19:24
Pomerantz LLP announces that a class action lawsuit has been filed against Hut 8 Corp. ("Hut 8" or the "Company") . The class action, filed in the United States District Court for the Southern District of New York, and docketed under 24 -cv-01636, is...

at 19:18
Sunlogix Energy, an Inc. 5000 recognized leading solar energy company is thrilled to announce the strategic acquisition of Desert Tech AC & Heating, a premier HVAC service provider in Coachella Valley, CA. This acquisition marks a significant...

at 19:07
Lumine Group Inc. ("Lumine Group" or "the Company") announces financial results for the three and twelve months ended December 31, 2023. All amounts referred to in this press release are in US dollars unless otherwise stated. The following press...

at 18:55
Brookfield Infrastructure Partners L.P. ("Brookfield Infrastructure") today announced that BIP Investment Corporation ("BIPIC"), a wholly-owned subsidiary of Brookfield Infrastructure, has determined the fixed dividend rate on its Senior Preferred...

at 18:35
Redwire Corporation today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023, after market close on Thursday, March 14, 2024. Management will conduct a conference call starting at 9 a.m. ET...

at 18:17
Telix Pharmaceuticals Limited today announces it has entered into an agreement to acquire radioisotope production technology firm ARTMS Inc. (ARTMS), its advanced cyclotron-based isotope production platform, manufacturing plant and stockpile of...



News published on and distributed by: